These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 12569024

  • 1. Microsphere entrapped bee-venom phospholipase A2 retains specific IgE binding capacity: a possible use for oral specific immunotherapy.
    Guérin V, Dubarryr M, Robic D, Brachet F, Rautureau M, André C, Bourbouze R, Tomé D.
    J Microencapsul; 2002; 19(6):761-5. PubMed ID: 12569024
    [Abstract] [Full Text] [Related]

  • 2. A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles.
    Martínez Gómez JM, Fischer S, Csaba N, Kündig TM, Merkle HP, Gander B, Johansen P.
    Pharm Res; 2007 Oct; 24(10):1927-35. PubMed ID: 17541735
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the immune response to allergens by immunosuppressive allergenic fragments. 1. Peptic fragments of honey bee venom phospholipase A2.
    Litwin A, Pesce AJ, Michael JG.
    Int Arch Allergy Appl Immunol; 1988 Oct; 87(4):361-6. PubMed ID: 3147947
    [Abstract] [Full Text] [Related]

  • 4. Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis.
    von Garnier C, Astori M, Kettner A, Dufour N, Heusser C, Corradin G, Spertini F.
    Eur J Immunol; 2000 Jun; 30(6):1638-45. PubMed ID: 10898500
    [Abstract] [Full Text] [Related]

  • 5. Involvement of carbohydrate on phospholipase A2, a bee-venom allergen, in in vivo antigen-specific IgE synthesis in mice.
    Okano M, Nishizaki K, Satoskar AR, Yoshino T, Masuda Y, Harn DA.
    Allergy; 1999 Aug; 54(8):811-8. PubMed ID: 10485384
    [Abstract] [Full Text] [Related]

  • 6. The frequency of phospholipase A2 binding of basophilic granulocytes does not decrease during bee-venom-specific immunotherapy.
    Irsch J, König C, Löhndorf A, Tesch H, Krieg T, Merk H, Radbruch A, Hunzelmann N.
    Allergy; 1999 Jul; 54(7):742-7. PubMed ID: 10442531
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy.
    Corthésy B, Lassus A, Terrettaz J, Tranquart F, Bioley G.
    Allergy; 2016 Jul; 71(7):957-66. PubMed ID: 26850222
    [Abstract] [Full Text] [Related]

  • 8. Intralymphatic injections as a new administration route for allergen-specific immunotherapy.
    Martínez-Gómez JM, Johansen P, Erdmann I, Senti G, Crameri R, Kündig TM.
    Int Arch Allergy Immunol; 2009 Jul; 150(1):59-65. PubMed ID: 19339803
    [Abstract] [Full Text] [Related]

  • 9. Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy.
    Kämmerer R, Chvatchko Y, Kettner A, Dufour N, Corradin G, Spertini F.
    J Allergy Clin Immunol; 1997 Jul; 100(1):96-103. PubMed ID: 9257793
    [Abstract] [Full Text] [Related]

  • 10. To bee or not to be? T-cell responses to bee venom PLA2 in relation to anaphylaxis and immunotherapy.
    McHugh SM.
    Clin Exp Allergy; 1997 Sep; 27(9):986-90. PubMed ID: 9678827
    [No Abstract] [Full Text] [Related]

  • 11. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers.
    Boonpiyathad T, Meyer N, Moniuszko M, Sokolowska M, Eljaszewicz A, Wirz OF, Tomasiak-Lozowska MM, Bodzenta-Lukaszyk A, Ruxrungtham K, van de Veen W.
    Allergy; 2017 Mar; 72(3):407-415. PubMed ID: 27341567
    [Abstract] [Full Text] [Related]

  • 12. Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres.
    Jilek S, Walter E, Merkle HP, Corthésy B.
    J Allergy Clin Immunol; 2004 Oct; 114(4):943-50. PubMed ID: 15480340
    [Abstract] [Full Text] [Related]

  • 13. Delineation of PLA2 epitopes using short or long overlapping synthetic peptides: interest for specific immunotherapy.
    Kämmerer R, Kettner A, Chvatchko Y, Dufour N, Tiercy JM, Corradin G, Spertini F.
    Clin Exp Allergy; 1997 Sep; 27(9):1016-26. PubMed ID: 9678833
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the immune response to allergens: phospholipase A degradation products suppress IgG and IgE response in mice.
    Pesce AJ, Freisheim JM, Litwin A, Michael JG.
    Int Arch Allergy Appl Immunol; 1990 Sep; 92(1):88-93. PubMed ID: 2246080
    [Abstract] [Full Text] [Related]

  • 15. Immune response to bee venom. II. Quantitation of the absolute amounts of IgE and IgG antibodies by saturation analysis.
    Kemeny DM, Lessof MH.
    Int Arch Allergy Appl Immunol; 1987 Sep; 83(2):113-20. PubMed ID: 3583409
    [Abstract] [Full Text] [Related]

  • 16. A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2.
    Dudler T, Machado DC, Kolbe L, Annand RR, Rhodes N, Gelb MH, Koelsch K, Suter M, Helm BA.
    J Immunol; 1995 Sep 01; 155(5):2605-13. PubMed ID: 7544378
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic immunization of mice with phospholipase A2-loaded gas-filled microbubbles is protective against Th2-mediated honeybee venom allergy.
    Bioley G, Lassus A, Terrettaz J, Tranquart F, Corthésy B.
    Clin Exp Allergy; 2016 Jan 01; 46(1):153-62. PubMed ID: 25900397
    [Abstract] [Full Text] [Related]

  • 18. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
    Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Müller U, Blaser K.
    J Clin Invest; 1996 Oct 01; 98(7):1676-83. PubMed ID: 8833918
    [Abstract] [Full Text] [Related]

  • 19. Recombinant allergen-based IgE testing to distinguish bee and wasp allergy.
    Mittermann I, Zidarn M, Silar M, Markovic-Housley Z, Aberer W, Korosec P, Kosnik M, Valenta R.
    J Allergy Clin Immunol; 2010 Jun 01; 125(6):1300-1307.e3. PubMed ID: 20466415
    [Abstract] [Full Text] [Related]

  • 20. Antigen-independent suppression of the allergic immune response to bee venom phospholipase A(2) by DNA vaccination in CBA/J mice.
    Jilek S, Barbey C, Spertini F, Corthésy B.
    J Immunol; 2001 Mar 01; 166(5):3612-21. PubMed ID: 11207323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.